[Tianjin Pharmaceutical Industry: subsidiary entrusts the Pharmaceutical Research Institute to carry out the research and development work of X08]. According to the announcement of Tianjin Pharmaceutical Industry, Hubei Tianjin Pharmaceutical Research Institute Co., Ltd., a subsidiary of the company, entrusted Tianjin Pharmaceutical Research Institute Co., Ltd. (referred to as "Pharmaceutical Research Institute") to carry out the research and development of X08. The two sides signed a "technology development (entrustment) contract" with an amount of 2.8 million yuan.